Biotech Specialty Pharma

AFcell Medical

322 Route 46W Suite 150
Parsippany, NJ 07054 USA
Click for website

Research Sector Biotech Specialty Pharma

Summary Description Delivers the natural function of the Amniotic membrane for surgery.

Management Robin Young, Founder and CEO; Howard Wolek, Vice President of Sales and General Manager; Alex Canonaco, R&D

Click here for Financial Data
Keywords: Amniotic membrane, biotech, af cell, af cell medical, afcellmedical, orthopaedics, orthopeadics, bio tech, AmnioClear, biomaterial, China, OR, operating room, ortho, Surgery, Infection Control


Updated: Dec. 08, 2015


AFcell recognized the true potential of a natural material, and that the market was open for a nimble company with strong science to step in and take the lead. Understanding the protective function......view more

Products / Services

AmnioClear is recovered from human donors who are undergoing a Ceasarean Section birth. Each placental donor provides enough amniotic membrane to cover, on average, a 15 cm by 15 cm space. AFCell thr......view more

Technology / Differentiation

The human body relies extensively on a thin, elastic membrane network to position, tone, cover, lubricate, protect and allow articulating hard and soft tissues (e.g. muscles) to glide freely and are, ...view more